Advertisement

x

Mathews Journal of Cancer Science

2474-6797
1
Chang-Ming Charlie Ma

Director, Vice Chairman, Professor
Fox Chase Cancer Center
United States

Biography

Dr. C-M Charlie Ma received his Ph.D. in medical physics from the University of London, London, the UK in 1992. Dr. Ma continued his radiation therapy research and clinical training at the Royal Marsden Hospital/Institute of Cancer Research, London, UK until 1993. He was a research officer at the National Research Council of Canada, Ottawa, Canada from 1993 to 1996, and an associate professor at StanfordUniversity, Stanford, CA from 1996 to 2001. Currently, he is Professor, Director of Radiation Physics and Vice Chairman of the Department of Radiation Oncology at Fox Chase Cancer Center (FCCC), Philadelphia, PA. Dr. Ma is recognized internationally as an expert in Monte Carlo simulation, radiation dosimetry, radiobiology, image guidance, plan optimization and treatment delivery for advanced radiation therapy, photodynamic therapy, focused ultrasound therapy and radio dynamic therapy. He has edited 4 books and published more than 20 book chapters and 180 peer-reviewed journal articles in these areas. He was elected Fellow of American College of Medical Physics (ACMP), American Association of Physicists in Medicine (AAPM), American Society for Radiation Oncology (ASTRO), and Institute of Physics (IOP), and served as a member on numerous professional committees, journal editorial boards, and scientific review panels.

Research Interest

Monte Carlo simulation, radiation transport theory, radiation dosimetry, radiobiology, optical and radiation image guidance, treatment planning, and optimization, treatment delivery, verification, and treatment assessment for advanced radiation therapy, photodynamic therapy, focused ultrasound therapy and radio dynamic therapy.

Recently Published Articles
Research Article

Interactive Treatment Planning in High Dose-Rate Brachytherapy for Gynecological Cancer

Published : 03rd June 2022
Authors : Huan Liu1, Chenyang Shen2, Peter Klages2, Kevin Albuquerque2, Chang M Ma1*, Xun Jia2*
Citation : Chang-Ming Ma, Xun Jia, et al. (2022). Interactive Treatment Planning in High Dose-Rate Brachytherapy for Gynecological Cancer. Mathews J Cancer Sci. 7(2):31.

Case Report

Is Anaplastic Oligodendroglioma Prone to Extracranial Metastasis? A Case Report and Review of Literature

Published : 30th January 2022
Authors : Yanjun Zhang*#, Canliang Yuan*, Dequan Yu
Citation : Zhang Y, et al. (2022). Is Anaplastic Oligodendroglioma Prone to Extracranial Metastasis? A Case Report and Review of Literature. Mathews J Cancer Sci. 7(1):30.

Editorial note

On the Definition of Sievert and Its SI Unit

Published : 30th December 2021
Author : C-M Charlie Ma
Citation : Ma C-M. (2021). On the Definition of Sievert and Its SI Unit. Mathews J Cancer Sci. 6(1):29.

Research Article

A Clinical Study on Pulsed Low Dose Rate Radiation Therapy for Recurrent Cancers

Published : 21st December 2021
Authors : X Tong*, FS Luo, GR Yang, DP Wang, X Song, Y Chen, S Wu, N Zhang, QQ Xu, T Zhang, and J Li
Citation : Tong X. (2021). A Clinical Study on Pulsed Low Dose Rate Radiation Therapy for Recurrent Cancers. Mathews J Cancer Sci. 6(1):28.

Review Article

Clinical Applications of Pulsed Low Dose-Rate Radiation Therapy

Published : 21st May 2021
Author : Lili Chen
Citation : Chen L. (2021). Clinical Applications of Pulsed LowDose-Rate Radiation Therapy. Mathews J Cancer Sci. (6)1:27.

Research Article

The Role of Temozolomide-Irinotecan in Doxorubicin- Resistant Cell Lines of Recurrent Ewing’s Sarcoma, in A Patient Derived Orthotopic Xenograft (PDOX) with EWS-ERG Fusion and CDKN2A Loss: What Impact the Combination has in Real Life Practice?

Published : 08th October 2020
Authors : Maher Salamoon¹, Mehdi Balti², Bertrand Farnault³, Maher Saifo4, Ali Mahmoud5, Ahmad Khatib6, Manal Daghlawi7, Taisir Husein8, Mazen Kenj9, and Khaled Ghanem10
Citation : Salamoon M. (2020). The Role of Temozolomide-Irinotecan in Doxorubicin-Resistant Cell Lines of Recurrent Ewing’s Sarcoma, in A Patient Derived Orthotopic Xenograft (PDOX) with EWS-ERG Fusion and CDKN2A Loss: What Impact the Combination has in Real Life Practice?. Mathews J Cancer Sci. (5)1: 21.

Indexed
Root Indexing
J Gate
Scientific Indexing Services
Scilit
WolrdCat
Directory of Research Journals Indexing
Genamics JournalSeek
International Scientific Indexing
International Committee of Medical Journal Editors
CiteFactor
Subscribe

Subscribe to our RSS feed, be in touch with our articles, news, videos, reebies.

Antispam Code Generate new code

Creative Commons License

© 2015 Mathews Open Access Journals. All Rights Reserved.

Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at Mathewsopenaccess.com